Uji klinis Sirosis di Minnesota
7 studi untuk Sirosis mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- MNGI Digestive Health, PA, Minneapolis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06632444A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Mayo Clinic, Rochester, Rochester
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07325526Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Mayo Clinic, Rochester
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05832229National Liver Cancer Screening Trial
- Hennepin Healthcare, Minneapolis
- University of Minnesota, Minneapolis
Menerima pesertaFase 4
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06084234Fibrosis Lessens After Metabolic Surgery
- Mayo Clinic, Rochester
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06374875Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Allina Health, Virginia Piper Cancer Institute, Coon Rapids
- Virginia Piper Cancer Institute Mercy Hospital-Unity Campus, Fridley
- VPCI Oncology Research, Minneapolis
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT05181826Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
- Mayo Clinic, Rochester
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 5 Sep 2025 · NCT05490888Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.